Literature DB >> 22334867

Pros and cons of phage therapy.

Catherine Loc-Carrillo1, Stephen T Abedon.   

Abstract

Many publications list advantages and disadvantages associated with phage therapy, which is the use of bacterial viruses to combat populations of nuisance or pathogenic bacteria. The goal of this commentary is to discuss many of those issues in a single location. In terms of "Pros," for example, phages can be bactericidal, can increase in number over the course of treatment, tend to only minimally disrupt normal flora, are equally effective against antibiotic-sensitive and antibiotic-resistant bacteria, often are easily discovered, seem to be capable of disrupting bacterial biofilms, and can have low inherent toxicities. In addition to these assets, we consider aspects of phage therapy that can contribute to its safety, economics, or convenience, but in ways that are perhaps less essential to the phage potential to combat bacteria. For example, autonomous phage transfer between animals during veterinary application could provide convenience or economic advantages by decreasing the need for repeated phage application, but is not necessarily crucial to therapeutic success. We also consider possible disadvantages to phage use as antibacterial agents. These "Cons," however, tend to be relatively minor.

Entities:  

Year:  2011        PMID: 22334867      PMCID: PMC3278648          DOI: 10.4161/bact.1.2.14590

Source DB:  PubMed          Journal:  Bacteriophage        ISSN: 2159-7073


  24 in total

Review 1.  Effect of antibiotics in the environment on microbial populations.

Authors:  Chang Ding; Jianzhong He
Journal:  Appl Microbiol Biotechnol       Date:  2010-05-28       Impact factor: 4.813

Review 2.  Biotechnological challenges of phage therapy.

Authors:  Mikael Skurnik; Maria Pajunen; Saija Kiljunen
Journal:  Biotechnol Lett       Date:  2007-03-16       Impact factor: 2.461

Review 3.  The potential of phages to prevent MRSA infections.

Authors:  Nicholas H Mann
Journal:  Res Microbiol       Date:  2008-04-26       Impact factor: 3.992

Review 4.  Phage therapy in clinical practice: treatment of human infections.

Authors:  Elizabeth Kutter; Daniel De Vos; Guram Gvasalia; Zemphira Alavidze; Lasha Gogokhia; Sarah Kuhl; Stephen T Abedon
Journal:  Curr Pharm Biotechnol       Date:  2010-01       Impact factor: 2.837

Review 5.  Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.

Authors:  P A Barrow; J S Soothill
Journal:  Trends Microbiol       Date:  1997-07       Impact factor: 17.079

Review 6.  Bacteriophage therapy.

Authors:  W C Summers
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

Review 7.  Antibiotics for emerging pathogens.

Authors:  Michael A Fischbach; Christopher T Walsh
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

8.  Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy.

Authors:  Rosanna Capparelli; Nunzia Nocerino; Marco Iannaccone; Danilo Ercolini; Marianna Parlato; Medaglia Chiara; Domenico Iannelli
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

Review 9.  Antibacterial resistance: current problems and possible solutions.

Authors:  Rashmi Sharma; Chaman Lal Sharma; Bhuvneshwar Kapoor
Journal:  Indian J Med Sci       Date:  2005-03

10.  Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.

Authors:  Maya Merabishvili; Jean-Paul Pirnay; Gilbert Verbeken; Nina Chanishvili; Marina Tediashvili; Nino Lashkhi; Thea Glonti; Victor Krylov; Jan Mast; Luc Van Parys; Rob Lavigne; Guido Volckaert; Wesley Mattheus; Gunther Verween; Peter De Corte; Thomas Rose; Serge Jennes; Martin Zizi; Daniel De Vos; Mario Vaneechoutte
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

View more
  218 in total

1.  Targeted Depletion of Bacteria from Mixed Populations by Programmable Adhesion with Antagonistic Competitor Cells.

Authors:  See-Yeun Ting; Esteban Martínez-García; Shuo Huang; Savannah K Bertolli; Katherine A Kelly; Kevin J Cutler; Elizabeth D Su; Hui Zhi; Qing Tang; Matthew C Radey; Manuela Raffatellu; S Brook Peterson; Víctor de Lorenzo; Joseph D Mougous
Journal:  Cell Host Microbe       Date:  2020-05-28       Impact factor: 21.023

2.  Bi- and Multi-directional Gene Transfer in the Natural Populations of Polyvalent Bacteriophages, and Their Host Species Spectrum Representing Foodborne Versus Other Human and/or Animal Pathogens.

Authors:  Ekaterine Gabashvili; Saba Kobakhidze; Stylianos Koulouris; Tobin Robinson; Mamuka Kotetishvili
Journal:  Food Environ Virol       Date:  2021-01-23       Impact factor: 2.778

3.  Paenibacillus larvae-Directed Bacteriophage HB10c2 and Its Application in American Foulbrood-Affected Honey Bee Larvae.

Authors:  Hannes Beims; Johannes Wittmann; Boyke Bunk; Cathrin Spröer; Christine Rohde; Gabi Günther; Manfred Rohde; Werner von der Ohe; Michael Steinert
Journal:  Appl Environ Microbiol       Date:  2015-06-05       Impact factor: 4.792

4.  Experimental approach for bacteriophage susceptibility testing of planktonic and sessile bacterial populations - Study protocol.

Authors:  Alina Cristina Neguţ; Oana Săndulescu; Marcela Popa; Anca Streinu-Cercel; Zemphira Alavidze; Ioana Berciu; Coralia Bleotu; Mircea Ioan Popa; Mariana Carmen Chifiriuc; Adrian Streinu-Cercel
Journal:  Germs       Date:  2014-12-01

5.  The impact of orally administered phages on host immune response and surrounding microbial communities.

Authors:  Yingying Hong; Jyothi Thimmapuram; Jiayi Zhang; Clayton K Collings; Ketaki Bhide; Kyle Schmidt; Paul D Ebner
Journal:  Bacteriophage       Date:  2016-07-13

6.  Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution.

Authors:  Johannes Cairns; Lutz Becks; Matti Jalasvuori; Teppo Hiltunen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-01-19       Impact factor: 6.237

Review 7.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

8.  Quantitative and synthetic biology approaches to combat bacterial pathogens.

Authors:  Feilun Wu; Jonathan H Bethke; Meidi Wang; Lingchong You
Journal:  Curr Opin Biomed Eng       Date:  2017-10-24

Review 9.  Phage Biocontrol of Campylobacter: A One Health Approach.

Authors:  Sophie Kittler; Severin Steffan; Elisa Peh; Madeleine Plötz
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

10.  Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.

Authors:  Marine Henry; Rob Lavigne; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.